Benten Biotech

We turn biotechnological challenges into patentable, scalable solutions.

Benten Biotech is a Uruguayan laboratory specializing in animal health. We design and implement innovative products, transfer production-ready technologies, conduct testings, and supply standardized reagents to various countries.

What we do

We offer customized development and innovation services, and we have over 100 products available for worldwide shipping.

I+D+i Services

Products

How we do it

We know what’s holding you back. We heard it from inside the industry:

“It’s expensive and there’s a good chance it won’t work.”

True, if there’s no clear strategy. That’s why we work in phases, with validated technical milestones, go/no-go decisions, and a methodology that reduces uncertainty from the start.
“We lack internal capabilities.”

We combine a technological platform, a technical and scientific team, and regulatory expertise. You focus on your business; we cover the execution with specialists in our technologies.
“We don’t know how to start or how to measure.”

We designed a roadmap with concrete deliverables, clear metrics, and a comprehensive vision: we considered regulation, scaling, and market launch from day one.
“We already tried that and it didn’t work.”

Often, it’s not the idea that fails, it’s the execution that fails. We redirect developments with focus, realism, and control of technical and strategic risk.
“We don’t have time for slow failures.”

Neither do we. We prioritize tangible progress, quick decisions, and developments that not only solve a technical problem, but also build a protectable and valuable asset.

In short, we bring science, innovation, business strategy, and patentability together in a single innovation plan aligned with your business objectives.

Results that speak for themselves

+90% of our projects meet their objectives on time and budget.
+20 innovation projects and R+D+i services completed to date.
+12 international clients operating in 9 countries.
+1M more than 1 million dollars of public funds executed in co-financing.
+3M more than 3 million dollars of private funds executed.
18 months average duration of R&D&I projects up to the preclinical studies stage.

What they think of us

“In our experience as a global company, Benten Biotech has proven to be a reliable organization, with a high level of scientific knowledge and a clear focus on innovation. Their support has been fundamental in the design and development of products, and in the implementation of cutting-edge analytical techniques that meet the highest quality standards. They are distinguished not only by their technical capacity, but also by their flexibility and professionalism. Thanks to this level of commitment, Benten Biotech has established itself as a partner that boosts our internal capabilities and allows us to advance more quickly in a highly competitive environment.”

Daniel Diaz CMO Global Director - Valo BioMedia
“The interaction with Benten Biotech has been extremely valuable professionally. Their team has a solid scientific background, commitment, and a collaborative attitude that has enriched every stage of our joint development. Their strategic focus and technical maturity have contributed to achieving significant and reliable advances, reflecting a serious and effective collaboration.”

Pablo Halperin Executive Manager of R&D - CDV
“Benten Biotech has been a consultant for our veterinary vaccine company for several years, and we are very grateful for the quality of their technical service, their versatility, and their timely response. In every case, we have received excellent customer service, evidenced by their availability for remote technical follow-up and on-site visits, which have contributed to successful technology transfers in the various projects we have undertaken.”

Zulma Suárez R&D Director - VECOL S.A.
“When it comes to finding solutions and working quickly, Benten has delivered. In a short time, the project team demonstrated strong proof-of-concept for assays based on their camelid nanobodies, then quickly pursued optimization. When one of the assay models did not perform as expected, the Benten team objectively evaluated their data, took critical comments seriously, and ultimately produced a better model. Communication with Benten was facile and timely, they were extremely patient, and they were consistently eager to work with us to develop the best solution for our needs. I am personally quite impressed by my experience with Benten Biotech and will strongly consider them in the future.”

Jeremy Rush SR AD - Global animal health company (USA)

Can you relate?

If you’re investing in R&D without clear results, or you want to accelerate the development of a vaccine, test, or technology, we can help you move forward with strategy, speed, and protection.

Schedule a 30-minute call and find out if your project is viable, scalable, and patentable.

Book now or write to us at estebanguerra@bentenbiotech.com

Innovating with purpose starts with a conversation.